Sphingosine kinase 1 (SphKI) is a sphingoiipid enzyme associated with tumor development as well as tumor's resistance to chemotherapeutic treatment. This study will investigate the potential utilities of novel SphKI inhibitors as anti-cancer agents for acute myeloid leukemia.
Showing the most recent 10 out of 27 publications